Bio-engineered Stent Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028

  • Single User License $3500

Bio-engineered Stent Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028

Status : August, 2020 | Medical Devices | PPT format

Report Digest


Global Bio-engineered Stent Market: Overview

The global bio-engineered stent market has grown steadily over the years, due to the advantages it provides to the heart patients. Bio-engineered stents are a type of device which consist of short plastic tube or narrow metal. These devices are extensively used in order to treat blocked arteries. Therefore, bio-engineered stent is gaining its maximum popularity among the patients who are suffering from several types of cardiovascular disorders or diseases such as ischemic heart disease and coronary heart disease.

A wide range of bio-engineered stent are available in market to treat numerous diseases such as peripheral arterial disease, coronary artery disease, carotid artery disease, abdominal aortic aneurysm, renal artery stenosis, and thoracic aortic aneurysm. Such USPs are majorly boosting the global bio-engineered stent market.

From the perspective of materials, the global bio-engineered stent market is segmented into cobalt alloy metal, stainless steel, tantalum, gold, nitinol, and polymers. Among them, the polymer segment showcases the lion’s share in the global bio-engineered stent market. This is due to its immense flexibility and success rates in the cases of different types of cardiovascular diseases. Moreover, bio-engineered stent can be manufactured by bio-erodible polymer, silicone, and polyurethane.

Global Bio-engineered Stent Market: Notable Developments

Some of the key developments highly contouring the shape of the global bio-engineered stent market in a positive way include:

  • In September 2018, one of the renowned company in the global bio-engineered stent market named as Biotronik SE & Co. KG had received the U.S Food and Drug Administration Approval (FDA) for coronary stent system in order to treat the acute coronary artery.
  • In October 2015, the company Medtronic Plc. had tested the drug-filled stent (DFS), where the drug was contained inside a reservoir, which was fixed inside of a bio-engineered stent. This drug was slowly eluted through a small laser-drilled holes in the outer core which was made of metal.

Some of the most prominent competitors operating in the competitive landscape of global bio-engineered stent market include –

  • Terumo Corporation
  • Biotronik SE &Co.
  • KG
  • Stentys Sao
  • Lombard Medical technologies

Global Bio-engineered Stent Market: Key Growth Drivers

Burgeoning Population Suffering from Renal and Cardiovascular Diseases to Boost Market

Bio-engineered stent plays a crucial role in expanding the blood vessel for preventing a blockage of arteries, especially in cardiovascular diseases. Thus, rising prevalence of different types of coronary heart diseases and growing population suffering from various cardiovascular diseases are propelling expansion in the global bio-engineered stent market. According to American Heart Association, a major population in the U.S is suffering from a few types of heart disorders and diseases, whereas a large number of people are suffering from the after-effects of stroke. According to World Health Organization (WHO), heart diseases have become the highest cause of mortality globally. However, bio-engineered stent acts as an alternative treatment to several cardiovascular diseases which brings the most positive results. Such factors are providing the major impetus to the growth of the global bio-engineered stent market.

Furthermore, apart from a wide range of cardiac problems, rising cases of several other diseases is also contributing demand in the global bio-engineered stent market. Growing prevalence of renal diseases and disorders is also fueling growth in the global bio-engineered stent market. However, governments’ stringent regulations for product type approvals and product type failure are the couple of challenges in the growth of the global bio-engineered stent market. Such challenges are responsible for obstructing the growth of the market. Nonetheless, persistent demand for bio-engineered stent from the healthcare industry in developing and developed regions is believed to overcome these challenges in the near future.

Global Bio-engineered Stent Market: Regional Outlook

With respect to geography, North America is leading the global bio-engineered stent market as the region has witnessed high expenditures in healthcare industry. Along with this, rising cases of cardiac ailments and growing prevalence of obesity are also responsible for fueling demand in the bio-engineered stent market in this region.

The study presents a granular assessment and quantitative evaluation of:

  • Key growth factors and prominent trends
  • Size and share of key segments in overall market
  • Key challenges and winning imperatives
  • Factors shaping competitive landscape
  • Insights into how contours of market will change in coming years
  • Technological advances
  • New avenues and imminent investment pockets
  • Regulatory landscape shaping current and future strategies of companies

The region-wise assessment includes market dynamics in:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.

The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:

  • Which key factors will shape the competitive landscape?
  • Which trends will stimulate research and development activities in different geographies?
  • Which are the lucrative growth areas and what is the size of potential they are likely contribute to the overall market?
  • Which disruptions in market growth are likely to come with the new business models?
  • Which are some of the recent overhauls in policies that may change the course of the market significantly?
  • Which are the geographies that will form sizable sources of new streams to new and established players alike?
  • How are top players likely to realign their strategy to counter the forces of competition?
  • Which key strategies emerging players are likely to focus on to consolidate their position?
  • Which changes in end-user preferences might affect the status quo held by the leading players?
  • Which are some of the game-changing innovations influencing the projected share and revenue of the market and its segments?

Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.